0. Record of Amendments
- 1 Mins to read
- DarkLight
0. Record of Amendments
- 1 Mins to read
- DarkLight
Article summary
Did you find this summary helpful?
Thank you for your feedback
DCT Feasibility Assessment
Australia
The below version control table serves to document all updates made to the guidebook. The purpose is to ensure the information is always accurate and up-to-date.
| Version Number | Publishing Date | Section(s) Updated & Reason(s) for Update |
|---|---|---|
| V0 | June 2023 | N/A (New Guidebook) |
| V1 | November 2023 | 2.17 - Addition of state-based guidance on Teletrials 2.19 - Addition of Medicines Australia Toolkit and ARCS White Paper 5.6, 5.7, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7 - Link to updated National Standard Operating Procedures for Clinical Trials including Teletrials |
| V2 | December 2023 | 7.2, 7.3, 8.3 - Additional details provided to clarify the answer 8.3 - Addition of link to Guideline on Computerized Systems and Electronic Data in Clinical Trials |
| V3 | January 2024 | Updated text, references, and links throughout the entire guidebook |
Disclaimers
A) At RegASK, we are committed to providing our clients with the most up-to-date and accurate information on regulatory requirements and compliance. To ensure the highest level of accuracy and relevance, we regularly review and update our e-guidebooks at least twice per year to reflect the latest regulatory developments in the market. In the meantime, our RegAlerts service is designed to keep our clients notified of any regulatory updates that may impact their business.
B) The contents on this platform are exclusively intended for the use of RegASK and its authorized representatives. All materials herein are confidential and the sole property of RegASK. Any reproduction, distribution, or display of this content to others is strictly prohibited without the express written consent of RegASK.
Was this article helpful?